Solvonis reports positive progress on European patent for Awakn collab
Solvonis Therapeutics PLC on Wednesday reported ‘positive progress’ on its European patent application for the Awkn-Sdn-14 programme.
The London-based biotechnology company aiming to develop innovative treatments...
Wed, 26/03/2025 - 13:43